- Home
- RKDA vs RDHL Comparison
RKDA vs RDHL Comparison
Compare RKDA & RDHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RKDA | RDHL |
|---|---|---|
| Founded | 2002 | 2009 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Agricultural Chemicals | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1M | 4.0M |
| IPO Year | 2015 | 2012 |
Fundamental Metrics
Financial Performance| Metric | RKDA | RDHL |
|---|---|---|
| Price | $0.43 | $0.58 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 62.3K | ★ 2.5M |
| Earning Date | 05-07-2026 | 04-27-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 66.92 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $4,858,000.00 | N/A |
| Revenue This Year | $61.67 | $381.91 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.38 | $0.57 |
| 52 Week High | $6.71 | $2.79 |
Technical Indicators
Market Signals| Indicator | RKDA | RDHL |
|---|---|---|
| Relative Strength Index (RSI) | 36.03 | 39.44 |
| Support Level | $0.38 | N/A |
| Resistance Level | $0.55 | $0.85 |
| Average True Range (ATR) | 0.04 | 0.11 |
| MACD | 0.00 | -0.01 |
| Stochastic Oscillator | 20.69 | 1.45 |
Price Performance
Historical ComparisonAbout RKDA Arcadia Biosciences Inc.
Arcadia Biosciences Inc is a company with science-based approaches to develop high value products and drive innovation in the consumer goods industry. The company has one operating and reportable segment, which derives revenue from the sale of Zola coconut water. The company's consumer brands in the food, beverage, and body care categories, and others. Its products include: Zola Coconut Water, and Agronomic Wheat Traits. Geographically, the company operates in United States, Argentina, India, and Canada. It derives maximum revenue from United States.
About RDHL Redhill Biopharma Ltd.
RedHill Biopharma Ltd is a specialty biopharmaceutical company mainly focused on the U.S. development and commercialization of drugs for GI diseases, infectious diseases, and oncology. The Company is mainly focused on the advancement of its development pipeline of clinical-stage therapeutic candidates and also commercializes its GI-related product, Talicia (omeprazole, amoxicillin, and rifabutin) in the U.S. Its therapeutic candidates include opaganib, RHB-204, RHB-104, RHB-102 (Bekinda), and RHB-107.